General Information of This Antibody-drug Conjugate (ID: DRG0XWTYJ)
ADC Name
DXC005
Synonyms
DXC005; DXC-005
   Click to Show/Hide
Organization
Hangzhou DAC Biotechnology (DAC Biotech) (Originator)
Drug Status
Phase 1
Drug-to-Antibody Ratio
4.0~4.2
Antibody Name
Anti-Muc1 antibody
 Antibody Info 
Antigen Name
Mucin-1 (MUC1)
 Antigen Info 
Payload Name
Tub201
 Payload Info 
Payload Target
Microtubule (MT)
 Target Info 
Linker Name
Undisclosed
Conjugate Type
Random Cysteines
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC
Disease Name Phase 1 Phase 2 Phase 3 Approved
Unspecific solid tumor
1 Trials
Clinical trial identifier
CTR20220117